Maravai LifeSciences Holdings, Inc. MRVI Cygnus — Adjusted EBITDA for reportable segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.
Tagged under the XBRL concept mrvi:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization.
The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Maravai LifeSciences Holdings, Inc.'s cygnus — adjusted ebitda for reportable segments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Maravai LifeSciences Holdings, Inc.'s cygnus — adjusted EBITDA for reportable segments?
- Maravai LifeSciences Holdings, Inc. (MRVI) reported cygnus — adjusted EBITDA for reportable segments of $13.56M in Q1 2026.
- How has Maravai LifeSciences Holdings, Inc.'s cygnus — adjusted EBITDA for reportable segments changed year-over-year?
- Maravai LifeSciences Holdings, Inc.'s cygnus — adjusted EBITDA for reportable segments increased by 7.0% year-over-year, from $12.67M to $13.56M.
- What does cygnus — adjusted EBITDA for reportable segments mean?
- Measures the core operational profitability of the Cygnus segment by excluding interest, taxes, depreciation, amortization, and non-recurring charges. This metric provides a normalized view of the segment's ability to generate cash flow from its primary business activities, facilitating performance comparisons across different reporting periods.